Abiopharma

🔍 Lazarus Edward P (Executive)

Company: Sonos Inc (SONO)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Acquired 42,983 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 518,670.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 21,314 shares of Common Stock at $16.59 per share (Direct)
  Date: 2026-08-14 | Code: F | equity_swap_involved: 0 | shares_owned_after: 497,356.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 8,960 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 214,191.00 | transaction_form_type: 4 | Footnotes: F2, F1, F4, F4
• Sold 15,117 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 199,074.00 | transaction_form_type: 4 | Footnotes: F2, F1, F5, F5
• Sold 18,906 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 180,168.00 | transaction_form_type: 4 | Footnotes: F2, F1, F6, F6

Footnotes:

• F1: Vesting of restricted stock units ("RSUs") previously granted to the Reporting Person.
• F2: Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon vesting and settlement for no consideration.
• F3: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were withheld by the Issuer in accordance with the agreement governing the RSUs to satisfy federal and state tax withholding obligations of the Reporting Person resulting from the vesting and settlement of RSUs.
• F4: These RSUs will vest based on the following schedule: (i) 1/12 of the shares subject to the RSUs vested on November 15, 2024 and (ii) the remaining RSUs vest quarterly over the next eleven quarters in equal quarterly installments, until such time as the RSUs are 100% vested, in each case subject to the continuing employment of the Reporting Person on each vesting date. The RSUs are subject to double-trigger acceleration.
• F5: These RSUs will vest over a two year period as follows: 1) 15% of the shares subject to the RSUs will vest quarterly in year 1 following the vesting commencement date of November 15, 2024 and 2) 10% of the shares subject to the RSUs will vest quarterly in year 2, in each case subject to the continuing employment of the Reporting Person on each vesting date. The RSUs are subject to double-trigger acceleration.
• F6: 1/12 of the shares subject to the RSUs vest in equal installments on each quarterly anniversary date following the applicable vesting commencement date of until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. The RSUs are subject to double-trigger acceleration.